Literature DB >> 21494343

A case of ropinirole-induced psychosis.

Sandeep Grover, Abhishek Ghosh.   

Abstract

Entities:  

Year:  2010        PMID: 21494343      PMCID: PMC3067990          DOI: 10.4088/PCC.10l00987gre

Source DB:  PubMed          Journal:  Prim Care Companion J Clin Psychiatry        ISSN: 1523-5998


× No keyword cloud information.
  8 in total

1.  A five-year study of the incidence of dyskinesia in patients with early Parkinson's disease who were treated with ropinirole or levodopa.

Authors:  O Rascol; D J Brooks; A D Korczyn; P P De Deyn; C E Clarke; A E Lang
Journal:  N Engl J Med       Date:  2000-05-18       Impact factor: 91.245

2.  Pramipexole, ropinirole, and mania in Parkinson's disease.

Authors:  Abhay Singh; Robert Althoff; R Jared Martineau; James Jacobson
Journal:  Am J Psychiatry       Date:  2005-04       Impact factor: 18.112

3.  Psychosis related to ropinirole.

Authors:  Elena Perea; Brian V Robbins; Burton Hutto
Journal:  Am J Psychiatry       Date:  2006-03       Impact factor: 18.112

4.  Ropinirole in treatment-resistant depression: a 16-week pilot study.

Authors:  Paolo Cassano; Lorenzo Lattanzi; Maurizio Fava; Serena Navari; Giulia Battistini; Marianna Abelli; Giovanni B Cassano
Journal:  Can J Psychiatry       Date:  2005-05       Impact factor: 4.356

5.  A method for estimating the probability of adverse drug reactions.

Authors:  C A Naranjo; U Busto; E M Sellers; P Sandor; I Ruiz; E A Roberts; E Janecek; C Domecq; D J Greenblatt
Journal:  Clin Pharmacol Ther       Date:  1981-08       Impact factor: 6.875

6.  An exploratory retrospective evaluation of ropinirole-associated psychotic symptoms in an outpatient population treated for restless legs syndrome or Parkinson's disease.

Authors:  Steven C Stoner; Megan M Dahmen; Mignon Makos; Jessica W Lea; Lora J Carver; Rafia S Rasu
Journal:  Ann Pharmacother       Date:  2009-08-18       Impact factor: 3.154

7.  Ropinirole for the treatment of early Parkinson disease: a 12-month experience. Ropinirole Study Group.

Authors:  K D Sethi; C F O'Brien; J P Hammerstad; C H Adler; T L Davis; R L Taylor; J Sanchez-Ramos; J M Bertoni; R A Hauser
Journal:  Arch Neurol       Date:  1998-09

8.  Update on ropinirole in the treatment of Parkinson's disease.

Authors:  Holly A Shill; Mark Stacy
Journal:  Neuropsychiatr Dis Treat       Date:  2009-04-08       Impact factor: 2.570

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.